Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis-Reference-Cited by-同舟云学术

Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis

Published:2010-07 Issue:7 Volume:22 Page:872-879
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Szamosi Tamas,Banai Janos,Lakatos Laszlo,Czegledi Zsofia,David Gyula,Zsigmond Ferenc,Pandur Tunde,Erdelyi Zsuzsanna,Gemela Orsolya,Papp Maria,Papp Janos,Lakatos Peter Laszlo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”

2. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down

3. Non-smoking: a feature of ulcerative colitis.

4. Smoking in Crohn's disease: effect on localisation and clinical course.

5. Inflammatory Bowel Disease: Is There Any Relation Between Smoking Status and Disease Presentation?

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of severe Crohn’s disease at a tertiary hospital in South Africa;South African Medical Journal;2024-04-18

2. A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn’s Disease Using a Brute Force Method;Diagnostics;2023-12-03

3. Matrix metalloproteinases in intestinal fibrosis;Journal of Crohn's and Colitis;2023-10-25

4. Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center;Inflammatory Bowel Diseases;2022-03-05

5. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review;The Surgeon;2021-10